spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Javelin Pharmaceuticals 

 HSMN NewsFeed - 6 Apr 2021
Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 22 Feb 2011
POZEN Announces Addition to Commercial Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jul 2010
Douglas G. Watson, Former CEO of Novartis Corporation, Joins Delcath Board of Directors
Devices Drug Delivery Personnel
 HSMN NewsFeed - 8 Jun 2010
Myriad Pharmaceuticals Announces Intent to Focus on Oncology Portfolio
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2010
Hospira Announces Further Extension of Tender Offer for Shares of Javelin Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions Litigation
 HSMN NewsFeed - 3 Jun 2010
Javelin Commences Litigation against Hospira and Discus Acquisition Corporation, Asserts Hospira is in Breach of Merger Agreement and Specific Performance Provision Compels Completion of Merger
Biopharmaceuticals Mergers & Acquisitions Litigation
 HSMN NewsFeed - 19 Apr 2010
Hospira and Javelin Pharmaceuticals Enter Into Definitive Merger Agreement for Hospira to Acquire Javelin Pharmaceuticals; Hospira Will Initiate Tender Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Apr 2010
Myriad Pharmaceuticals Announces Termination of Merger Agreement With Javelin Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Apr 2010
Javelin Pharmaceuticals Announces Termination of Merger Agreement with Myriad Pharmaceuticals, Cancels Special Meeting of Stockholders
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Apr 2010
Myriad Pharmaceuticals Receives Notice of Javelin's Intent to Terminate Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Apr 2010
Javelin Pharmaceuticals Delivers Notice of Intent to Terminate Merger Agreement with Myriad Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Feb 2010
FDA Accepts Javelin Pharmaceuticals' Submission and Files New Drug Application for Dyloject(TM)
Biopharmaceuticals FDA Mergers & Acquisitions
 HSMN NewsFeed - 18 Dec 2009
Myriad Pharmaceuticals to Acquire Javelin Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Aug 2009
Javelin Pharmaceuticals Reports Ereska (Intranasal Ketamine) Phase III Trial Results in Postoperative Orthopedic Pain
Biopharmaceuticals Drug Delivery Surgery
 HSMN NewsFeed - 31 Jul 2008
Javelin Pharmaceuticals and Baxter Healthcare Corporation Expand Commercial Supply Relationship for Anticipated Dyloject(TM) Global Growth
Biopharmaceuticals
 HSMN NewsFeed - 16 Jun 2008
EyeGate Pharma Appoints Amy Cohen as Vice President, Clinical Operations
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 5 Jun 2008
Javelin Pharmaceuticals' Founder and President Transitions to Executive Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2008
Javelin Pharmaceuticals Appoints John C. Taylor as Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Mar 2008
Javelin Pharmaceuticals' Dyloject Accepted by Scottish Medicines Consortium (SMC)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 Mar 2008
Javelin Pharmaceuticals Board Appoints Industry Veteran Martin Driscoll as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Dec 2007
Javelin Pharmaceuticals Announces Peer-Reviewed Publication of Successful Postoperative Pain Trial with PMI-100/150 (Intranasal Ketamine) in International Journal, ''Acute Pain''
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 14 Dec 2007
Javelin Pharmaceuticals Announces Successful Dyloject Pivotal US Phase 3 Trial Top-Line Results at New York City Analyst Day
Biopharmaceuticals
 HSMN NewsFeed - 11 Dec 2007
Javelin Pharmaceuticals Launches Dyloject(R) in UK
Biopharmaceuticals
 HSMN NewsFeed - 31 Oct 2007
Javelin Pharmaceuticals Receives Marketing Authorization Approval for Dyloject(R) in the United Kingdom
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Jul 2007
Javelin Pharmaceuticals Begins Second Phase 3 Study of Dyloject(TM)
Biopharmaceuticals
 HSMN NewsFeed - 22 May 2007
Javelin Pharmaceuticals Signs Commercial Supply Agreement with Baxter Healthcare Corporation
Biopharmaceuticals
 HSMN NewsFeed - 21 Feb 2007
Javelin Pharmaceuticals Names Derek Gallacher as European Managing Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jan 2007
Javelin Pharmaceuticals Announces Results of FDA Meeting for Nasal Ketamine
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 12 Sep 2006
Javelin Pharmaceuticals, Inc. To Present Final Analysis of Phase 2b Study Results of Dyloject(TM) at Prestigious European Pain Conference - September 14, 2006
Biopharmaceuticals
 HSMN NewsFeed - 21 Jun 2006
Mark Matthews Joins Javelin Pharmaceuticals as VP of Commercial Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 May 2006
Javelin Enrolls First Patient in Pivotal Phase III Study of Rylomine(TM)
Biopharmaceuticals
 HSMN NewsFeed - 1 May 2006
Javelin Announces Initial Results of a Pilot Phase II Study Of Intranasal Ketamine In Postoperative Orthopedic Pain
 HSMN NewsFeed - 24 Apr 2006
Stephen Tulipano Joins Javelin Pharmaceuticals as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jan 2006
Preliminary Phase IIb Study Shows Dyloject(TM) Relieves Postoperative Pain Faster Than Ketorolac
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 3

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 3 additional stories matching:
Javelin Pharmaceuticals
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.